| [1] |
LI X Y, WANG J, GONG X,et al. Upregulation of BCL-2 by acridone derivative through gene promoter i-motif for alleviating liver damage of NAFLD/NASH[J].Nucleic Acids Research,2020,48(15):8255-8268. doi:10.1093/nar/gkaa615pmid:32710621 |
| [2] |
YUAN M, HE J, HU X,et al. Hypertension and NAFLD risk: Insights from the NHANES 2017-2018 and Mendelian randomization analyses[J].Chin Med J (Engl),2024,137(4):457-464. |
| [3] |
SONG C W, LV W, LI Y H,et al. Alleviating the effect of quinoa and the underlying mechanism on hepatic steatosis in high-fat diet-fed rats[J].Nutrition & Metabolism,2021,18(1):106. |
| [4] |
DINIZ T A, JUNIOR E A D L, TEIXEIRA A A,et al. Aerobic training improves NAFLD markers and insulin resistance through AMPK-PPAR-α signaling in obese mice[J].Life Sciences,2021,266:118868. |
| [5] |
ZHANG L J, LIU C H, YIN L F,et al. Mangiferin relieves CCl4-induced liver fibrosis in mice[J].Sci Rep,2023,13(1):4172. doi:10.1038/s41598-023-30582-3pmid:36914687 |
| [6] |
LIAO S L, HE H, ZENG Y P,et al. A nomogram for predicting metabolic steatohepatitis: The combination of NAMPT, RALGDS, GADD45B, FOSL2, RTP3, and RASD1[J].Open Medicine,2021,16(1):773-785. doi:10.1515/med-2021-0286pmid:34041361 |
| [7] |
WU X Z, YUAN C B, PAN J X,et al. CXCL9, IL2RB, and SPP1, potential diagnostic biomarkers in the co-morbidity pattern of atherosclerosis and non-alcoholic steatohepatitis[J].Scientific Reports,2024,14(1):16364. doi:10.1038/s41598-024-66287-4pmid:39013959 |
| [8] |
YAN J Y, FENG Y Y, FANG X W,et al. Anti-liver fibrosis effects of the total flavonoids of litchi semen on CCl4-induced liver fibrosis in rats associated with the upregulation of retinol metabolism[J].Pharmaceutical Biology,2022,60(1):1264-1277. |
| [9] |
沈颖筱, 施惠海, 罗家乐,等.非酒精性脂肪性肝病肝纤维化风险预测模型的应用与进展[J].实用临床医药杂志,2023,27(9):131-136, 142. |
|
SHEN Y X, SHI H H, LUO J L,et al. Application and progress of liver fibrosis risk prediction model for nonalcoholic fatty liver disease[J].J Clin Med Pract,2023,27(9):131-136, 142. |
| [10] |
赵梓硕, 朱玉光, 马燕山,等.不同高脂饲料配方对建立非酒精性脂肪肝大鼠模型的影响[J].中国临床药理学与治疗学,2024,29(5):543-553. |
|
ZHAO Z S, ZHU Y G, MA Y S,et al. Effects of different formulations of high-fat diet on establishment of a non-alcoholic fatty liver model in rats[J].Chin J Clin Pharmacol Ther,2024,29(5):543-553. |
| [11] |
张垚, 叶嘉豪, 范星宇,等.基于数据挖掘的肝硬化动物模型分析[J].湖北民族大学学报(医学版),2024,41(2):28-32. |
|
ZHANG Y, YE J H, FAN X Y,et al.Analysis of Animal Models of Cirrhosis Based on Data Mining[J].J Hubei Minzu Univ Med Ed,2024,41(2):28-32. |
| [12] |
PEI X L, LIU L, WANG J R,et al. Exosomal secreted SCIMP regulates communication between macrophages and neutrophils in pneumonia[J].Nature Communications,2024,15(1):691. doi:10.1038/s41467-024-44714-4pmid:38263143 |
| [13] |
LI Q S, FRANCKE S, SNOEYS J,et al. Genome-wide association study of abnormal elevation of ALT in patients exposed to atabecestat[J].BMC Genomics,2023,24(1):513. doi:10.1186/s12864-023-09625-6pmid:37658353 |
| [14] |
SUN X L, TIAN A X, LI P,et al.SCIMP:A Novel Targeted Gene for Postmenopausal Osteoporosis Progression[J].Orthopaedic Surgery,2023,15(5):1375-1383. |
| [15] |
朱海伟, 梁琳琅. 2型糖尿病合并非酒精性脂肪性肝病患者维生素D水平与肝纤维化的关系[J].中国临床研究,2023,36(5):670-674. |
|
ZHU H W, LIANG L L. Correlation between 25 Hydroxyvitamin D level and liver fibrosis in patients with type 2 diabetes mellitus and nonalcoholic fatty liver disease[J].Chin J Clin Res,2023,36(5):670-674. |